Baker Avenue Asset Management, LP Gilead Sciences, Inc. Transaction History
Baker Avenue Asset Management, LP
- $3.21 Billion
- Q1 2025
A detailed history of Baker Avenue Asset Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 2,490 shares of GILD stock, worth $255,996. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,490Holding current value
$255,996% of portfolio
0.01%Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
2,189Shares Held
990MCall Options Held
8.69MPut Options Held
9.39M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$11.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.37 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.21 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$5.96 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $129B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...